Yahoo Web Search

Search results

    • CellFE Announces May 2024 Conference Presentations

      Fairfield-Suisun Daily Republic· 2 days ago

      CellFE Inc., a life sciences tools company with a novel microfluidics-based cellular engineering platform, announced today an upcoming presentation by CSO Todd Sulchek, PhD ...

    • Analyst Report: Gilead Sciences, Inc.

      Morningstar Research via Yahoo Finance· 1 day ago

      Gilead Sciences develops and markets therapies to treat life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. The acquisitions ...

    • Q1 2024 Gilead Sciences Inc Earnings Call

      Thomson Reuters StreetEvents via Yahoo Finance· 1 day ago

      HIV product sales grew 4% year-over-year. Oncology product sales were up 18%, driven by Trodelvy, which is well established as the #1 regimen for second-line metastatic triple-negative breast ...